REQUEST A DEMO
Total
USD $0.00
Search more companies

Sopharmacy 25 EOOD (Софармаси 25 ЕООД) (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Sopharmacy 25 EOOD Profile Updated: September 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sopharmacy 25 EOOD (Софармаси 25 ЕООД) is an enterprise in Bulgaria, with the main office in Sofia. The enterprise operates in the Pharmacies and Drug Stores industry. It was incorporated on September 12, 2026. 27 (2024) employees currently work for Sopharmacy 25 EOOD (Софармаси 25 ЕООД). In 2024, the company reported a net sales revenue increase of 102.28%. Its’ total assets recorded a growth of 42.08%. In, 2024, the company’s net profit margin increased by 2.17%.

Headquarters
Iztok, Bul./Ul. Ul. Lachezar Stanchev 5, Sofarma Biznes Tauars, Sgrada A, ET. 13
Sofia; Sofia - city; Postal Code: 1756

Contact Details: Purchase the Sopharmacy 25 EOOD (Софармаси 25 ЕООД) report to view the information.

Basic Information
Total Employees:
Purchase the Sopharmacy 25 EOOD (Софармаси 25 ЕООД) report to view the information.
Registered Capital:
Purchase the Sopharmacy 25 EOOD (Софармаси 25 ЕООД) report to view the information.
Financial Auditors:
Purchase the Sopharmacy 25 EOOD (Софармаси 25 ЕООД) report to view the information.
Incorporation Date:
September 12, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sopharmacy 25 EOOD (Софармаси 25 ЕООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
102.28%
Total Operating Revenue
102.69%
Operating Profit
385.96%
EBITDA
242.99%
Net Profit/Loss for the Period
386.15%
Total Assets
42.08%
Total Equity
68.72%
Operating Profit Margin
1.9%
Net Profit Margin
2.17%
Return on Equity (ROE)
34.16%
Quick Ratio
0.11%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?